Protalix Biotherapeutics (PLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 54,693 | 34,240 | 21,078 | 9,199 | 4,364 |
| Cost of Goods | 10,895 | 9,302 | 15,231 | 8,398 | 730 |
| Gross Profit | 43,798 | 24,938 | 5,847 | 801 | 3,634 |
| Operating Expenses | 55,410 | 44,548 | 40,595 | 34,362 | 28,034 |
| Operating Income | -10,717 | -19,308 | -34,517 | -33,163 | -23,670 |
| Other Income | -7,559 | -7,149 | -48,923 | 3,987 | -3,612 |
| Pre-tax Income | -18,276 | -26,457 | -83,440 | -29,176 | -27,282 |
| Net Income Continuous | -18,276 | -26,457 | -83,440 | -29,176 | -27,282 |
| Net Income Discontinuous | N/A | N/A | N/A | -189 | 85,319 |
| Net Income | $-18,276 | $-26,457 | $-83,440 | $-29,365 | $58,037 |
| EPS Basic Total Ops | -1.23 | -1.80 | -6.37 | -2.90 | 6.10 |
| EPS Basic Continuous Ops | -1.23 | -1.80 | -6.37 | -2.90 | -2.90 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.02 | 9.00 |
| EPS Diluted Total Ops | -1.23 | -1.80 | -6.37 | -2.90 | 6.10 |
| EPS Diluted Continuous Ops | -1.23 | -1.80 | -6.37 | -2.90 | -2.90 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.02 | 9.00 |
| EPS Diluted Before Non-Recurring Items | -1.23 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-6,109 | $-15,035 | $-30,263 | $-30,612 | $-20,855 |